Form 4: Exagen Inc. Director Ana Hooker Acquires 9,000 Stock Options
SEC Form 4 Filing
Director Ana Hooker acquired 9,000 stock options in Exagen Inc. on June 10, 2024, at an exercise price of $1.99.
Summary
- On June 10, 2024, Ana Hooker, a director of Exagen Inc., acquired 9,000 stock options.
- The exercise price for these options is $1.99.
- The options vest and become exercisable on the earlier of the first anniversary of the grant date or the next annual meeting of Exagen's stockholders, contingent upon continued service on the board.
- The options expire on June 9, 2034.
- Following the transaction, Ana Hooker directly owns 9,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock option grants, which is neutral in sentiment.
Industry Context
This is a standard disclosure related to insider transactions, common for directors and officers of publicly traded companies.
Stakeholder Impact
- The transaction could have a minor impact on shareholders by potentially diluting equity if the options are exercised in the future.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of transaction: Ana Hooker acquired 9,000 stock options. |
| 06/09/2034 | Expiration date of the stock options. |
| 06/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.